BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9691216)

  • 1. Experimental vaccine strategies for cancer immunotherapy.
    Chen CH; Wu TC
    J Biomed Sci; 1998; 5(4):231-52. PubMed ID: 9691216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy of solid tumor: perspectives on vaccine and cell therapy].
    Ikeda H; Shiku H
    Nihon Rinsho; 2012 Dec; 70(12):2043-50. PubMed ID: 23259373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic cancer vaccines: From initial findings to prospects.
    Song Q; Zhang CD; Wu XH
    Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune based therapies in cancer.
    Krüger C; Greten TF; Korangy F
    Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of T-cell inhibition: implications for cancer immunotherapy.
    Mittendorf EA; Sharma P
    Expert Rev Vaccines; 2010 Jan; 9(1):89-105. PubMed ID: 20021308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector.
    Quinn M; Erkes DA; Snyder CM
    Immunotherapy; 2016 Feb; 8(2):211-21. PubMed ID: 26786895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccine for cancer immunotherapy.
    Yang B; Jeang J; Yang A; Wu TC; Hung CF
    Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-based strategies for the immunotherapy of cancer.
    Tüting T; Storkus WJ; Lotze MT
    J Mol Med (Berl); 1997 Jul; 75(7):478-91. PubMed ID: 9253711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model.
    Kontani K; Taguchi O; Ozaki Y; Hanaoka J; Tezuka N; Sawai S; Inoue S; Fujino S; Maeda T; Itoh Y; Ogasawara K; Sato H; Ohkubo I; Kudo T
    Cancer Gene Ther; 2002 Apr; 9(4):330-7. PubMed ID: 11960283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines.
    Fecek RJ; Storkus WJ
    Immunotherapy; 2016 Oct; 8(10):1205-18. PubMed ID: 27605069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gene therapy of cancer: transgenic immunotherapy.
    Zwiebel JA; Su N; MacPherson A; Davis T; Ojeifo JO
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):119-28; discussion 129. PubMed ID: 8303305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in GM-CSF-based cancer immunotherapy.
    Yan WL; Shen KY; Tien CY; Chen YA; Liu SJ
    Immunotherapy; 2017 Mar; 9(4):347-360. PubMed ID: 28303764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells in tumor immunology and immunotherapy.
    Turtle CJ; Hart DN
    Curr Drug Targets; 2004 Jan; 5(1):17-39. PubMed ID: 14738216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and future prospects of peptide-based cancer vaccines.
    Wada S; Yada E; Ohtake J; Fujimoto Y; Uchiyama H; Yoshida S; Sasada T
    Immunotherapy; 2016 Nov; 8(11):1321-1333. PubMed ID: 27993087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity.
    Whittington PJ; Radkevich-Brown O; Jacob JB; Jones RF; Weise AM; Wei WZ
    Cancer Immunol Immunother; 2009 May; 58(5):759-67. PubMed ID: 18836716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor vaccine: current trends in antigen specific immunotherapy.
    Baral R
    Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines for cancer.
    Boyd D; Hung CF; Wu TC
    IDrugs; 2003 Dec; 6(12):1155-64. PubMed ID: 14666426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation approaches for tumor vaccination.
    Patel A; Kaufman HL; Disis ML
    Chin Clin Oncol; 2017 Apr; 6(2):19. PubMed ID: 28482672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.